ORCL vs. HIMS

Last updated Jul 25, 2026

ORCL (Oracle Corporation) and HIMS (Hims & Hers Health, Inc.) are both stocks. ORCL operates in Software - Infrastructure (Technology), while HIMS operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, ORCL returned 7.00%/yr vs 26.71%/yr for HIMS. At a 0.26 correlation, their price movements are largely independent.

Performance

ORCL vs. HIMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oracle Corporation (ORCL) and Hims & Hers Health, Inc. (HIMS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ORCL achieves a -40.43% return, which is significantly lower than HIMS's -13.49% return.

ORCL

• 1D: -4.21%
• 1M: -26.75%
• 6M: -34.64%
• YTD: -40.43%
• 1Y: -52.11%
• 3Y*: 0.33%
• 5Y*: 7.00%
• 10Y*: 12.55%
• ALL TIME*: 21.12%

HIMS

• 1D: -14.20%
• 1M: -14.10%
• 6M: -5.17%
• YTD: -13.49%
• 1Y: -50.99%
• 3Y*: 50.14%
• 5Y*: 26.71%
• 10Y*: —
• ALL TIME*: 16.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
HIMS Hims & Hers Health, Inc.	$469.29M	$508.05M	$558.75M
ORCL Oracle Corporation	$5.20B	$5.34B	$5.04B

ORCL vs. HIMS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
ORCL Oracle Corporation	-40.43%	18.13%	59.99%	30.94%	-4.65%	36.89%	24.25%	-1.25%
HIMS Hims & Hers Health, Inc.	-13.49%	34.28%	171.69%	38.85%	-2.14%	-55.14%	47.47%	1.23%

Correlation

The correlation between ORCL and HIMS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.29
Correlation (3Y) Calculated over the trailing 3-year period	0.32
Correlation (5Y) Calculated over the trailing 5-year period	0.32
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019	0.26

Fundamentals

Market Cap ORCL : $331.23B HIMS : $6.27B
EPS ORCL : $5.86 HIMS : -$0.05
PS Ratio ORCL : 4.98 HIMS : 2.87
PB Ratio ORCL : 7.79 HIMS : 14.38
Total Revenue (TTM) ORCL : $67.36B HIMS : $2.37B
Gross Profit (TTM) ORCL : $79.58B HIMS : $1.70B
EBITDA (TTM) ORCL : $6.20B HIMS : $16.04M

Return for Risk

ORCL vs. HIMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORCL

ORCL Risk / Return Rank: 12
ORCL Sharpe Ratio Rank: 11
ORCL Sortino Ratio Rank: 10
ORCL Omega Ratio Rank: 13
ORCL Calmar Ratio Rank: 14
ORCL Martin Ratio Rank: 14

HIMS

HIMS Risk / Return Rank: 23
HIMS Sharpe Ratio Rank: 21
HIMS Sortino Ratio Rank: 23
HIMS Omega Ratio Rank: 24
HIMS Calmar Ratio Rank: 22
HIMS Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORCL vs. HIMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oracle Corporation (ORCL) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ORCL	HIMS	Difference
Sharpe ratio: Return per unit of total volatility	-0.80	-0.57	-0.23
Sortino ratio: Return per unit of downside risk	-1.32	-0.56	-0.76
Omega ratio: Gain probability vs. loss probability	0.86	0.94	-0.08
Calmar ratio: Return relative to maximum drawdown	-0.81	-0.66	-0.15
Martin ratio: Return relative to average drawdown	-1.31	-1.02	-0.29

ORCL vs. HIMS - Sharpe Ratio Comparison

The current ORCL Sharpe Ratio is -0.80, which is lower than the HIMS Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of ORCL and HIMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ORCL vs. HIMS - Drawdown Comparison

The maximum ORCL drawdown since its inception was -84.19%, roughly equal to the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for ORCL and HIMS.

Drawdown Indicators

	ORCL	HIMS	Difference
Max Drawdown Largest peak-to-trough decline	-84.19%	-87.29%	+3.10%
Max Drawdown (1Y) Largest decline over 1 year	-64.58%	-78.06%	+13.48%
Max Drawdown (3Y) Largest decline over 3 years	-64.58%	-78.88%	+14.30%
Max Drawdown (5Y) Largest decline over 5 years	-64.58%	-78.88%	+14.30%
Max Drawdown (10Y) Largest decline over 10 years	-64.58%	—	—
Current Drawdown Current decline from peak	-64.58%	-59.14%	-5.44%
Average Drawdown Average peak-to-trough decline	-29.18%	-43.35%	+14.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	39.95%	50.21%	-10.26%

Volatility

ORCL vs. HIMS - Volatility Comparison

The current volatility for Oracle Corporation (ORCL) is 14.18%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 23.91%. This indicates that ORCL experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ORCL	HIMS	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.18%	23.91%	-9.73%
Volatility (6M) Calculated over the trailing 6-month period	43.05%	71.82%	-28.77%
Volatility (1Y) Calculated over the trailing 1-year period	65.64%	90.35%	-24.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	42.75%	83.71%	-40.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.54%	77.38%	-41.84%

Dividends

ORCL vs. HIMS - Dividend Comparison

ORCL's dividend yield for the trailing twelve months is around 1.74%, while HIMS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HIMS Hims & Hers Health, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ORCL Oracle Corporation	1.74%	0.97%	0.96%	1.44%	1.57%	1.38%	1.48%	1.72%	1.68%	1.52%	1.56%	1.56%

Financials

Frequently Asked Questions

Can I hold both ORCL and HIMS in my portfolio?

ORCL and HIMS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ORCL or HIMS?

HIMS has higher volatility (23.91%) compared to ORCL (14.18%). In terms of maximum drawdown, ORCL dropped -84.19% vs HIMS's -87.29%.

Which has better risk-adjusted returns?

HIMS currently has the higher Sharpe Ratio (-0.57 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.